Irinotel 100mg/5ml

$72.60
Description

Irinotecan is activated by the reaction to SN-38, associated with the nursing matter of topoisomerase I. This is often then inactivated by glucuronidation by uridinediphosphateglucuronosyl enzyme 1A1 (UGT1A1). The inhibition of topoisomerase I by the active matter SN-38 eventually results in inhibition of each DNA replication and transcription

SKU 1496
Generic For Camptosar
Strength 100mg/5ml
Manufacturer Fresenius Kabi
Active Ingredient Irinotecan

Out Of Stock

This product is out of stock. To keep the track of product's availability, Kindly enter your email id below.
Add to Compare

Irinotel 100mg/(Irinotecan) – Affordable Camptosar Alternative

Irinotel 100 mg/5 ml (Irinotecan)

Irinotecan is the primary active ingredient present in the drug Irinotel 100 mg/5 ml. It is associated with anti-cancer ("antineoplastic" or "cytotoxic") therapy drug. This medication is classed as a "plant alkaloid" and "topoisomerase I substance. Irinotecan received accelerated approval by the U.S. Food and Drug Administration (FDA) in 1996 and full approval in 1998. Throughout development, it had been referred to as CPT-11. It's on the UN agency Model List of Essential Medicines, the foremost vital medications required in an exceedingly basic health system.

Irinotel drug general Information

What is Irinotel drug used for?

Irinotecan is a drug used for the treatment of cancer. Irinotecan prevents DNA from unreeling by inhibition of topoisomerase I. In chemical terms, it's an artificial analogue of the natural organic compound camptothecin. Its primary use is in carcinoma, particularly, together with different therapy agents.  

How does Irinotel drug works?

Irinotecan is activated by the reaction to SN-38, associated with the nursing matter of topoisomerase I. This is often then inactivated by glucuronidation by uridinediphosphateglucuronosyl enzyme 1A1 (UGT1A1). The inhibition of topoisomerase I by the active matter SN-38 eventually results in inhibition of each DNA replication and transcription.

What are the different doses of Irinotel? 

Irinotel drug combination is available in the form of intravenous injection only under onestrengthnamely:

  • Irinotel – 100 mg/5 ml

You can easily buy Irinotel 100 mg/5 ml injection online from our website premiumrxdrugs.com at a very reasonable price.

What does Irinotel drug contain?

This injection contains Irinotecan as the primary active ingredient.

What are the side effects of  Irinotel?

Some of the most common side effects related to the consumption of this drug are inflammation, itching, rashes, weight gain, profuse sweating, vertigo, problems in breathing, suffocation, dark urine, increased heart palpitation, cough, cold, nausea, vomiting, puffy face and neck, dizziness, change of vision, dull skin, and paralysis.

What medication interact with Irinotel?

Avoid consuming this drug along with bumetanide, furosemide, hydrochlorothiazide, gentamycin, tobramycin, amphotericin B, ibuprofen, tacrolimus, vancomycin.While using this medication, you ought to not be treated with alternative bisphosphonates, together with alternative brands of Irinotel accustomed forestall or treat bone loss (osteoporosis).

Always consult your physician and pharmacist if you are taking any other medicines, which are not prescribed such as herbal tonics, supplements, and medications

When should Irinotel not be used?

  • Irinotel 100 mg/5 ml should not be used if the patient is allergic to the composition of this drug
  • This medication should not be prescribed to children below ten years of age
  • Please consult your doctor before taking this medicine if you are planning to conceive or you are lactating women

How should Irinotel be used?

This medication should be injected intravenously after diluting with sufficient amount of water. When you buy this drug online, make sure to keep a note of all the instructions and precautions that needs to be followed. If you still have any query do consult your physician and do as instructed.

How long should Irinotel drug be used?

Use this medication as per the prescription of your doctor. The initial dose of this medication for adults is once every 3 to 4 weeks. Do not stop taking this medicine without the consent of your doctor even if your symptoms are subsided.

Missed dose of Irinotel drug:

If you have missed a dose of Irinotel 100 mg/ 5 ml, take is as soon as you remember. Please avoid taking any dose if it is already the time to take the next dose.  

How should Irinotel drug be stored?

Store this medicationin a cool, dry place and out of the reach of your children and pets. The medicines must not be used past the expiry date. Dispose of the wrapper properly. Do not refrigerate the drug.

 

Irinotel 100mg/5ml

What is Irinotecan and what condition does it treat?

Irinotecan is a chemotherapy medication classified as a topoisomerase inhibitor used to treat various types of cancer. Irinotel 100mg/5ml contains this active ingredient and is primarily prescribed for colorectal cancer, particularly metastatic disease that has spread beyond the colon. This cancer treatment medicine also treats pancreatic cancer in certain cases. Irinotecan works as part of combination chemotherapy regimens or as a single-agent therapy when other cancer medicines haven't been effective. This injectable oncology drug is administered by healthcare professionals in hospital or clinic settings to target rapidly dividing cancer cells throughout the body.

How does Irinotecan work in the body?

Irinotecan functions by blocking topoisomerase I, an essential enzyme that cancer cells need to copy their DNA and multiply. When Irinotel 100mg/5ml is administered, the active ingredient converts into its active form SN-38, which prevents cancer cells from repairing their genetic material during cell division. This chemotherapy agent causes DNA strand breaks that accumulate in rapidly dividing malignant cells, eventually triggering cancer cell death. Because tumour cells divide much faster than most healthy cells, this topoisomerase inhibitor preferentially targets cancerous tissue while allowing normal cells time to recover between treatment cycles.

How long does Irinotel 100mg/5ml take to work?

Irinotel 100mg/5ml begins working at the cellular level within hours of infusion, but measurable anti-cancer effects take considerably longer to become apparent. Most oncologists assess tumour response through imaging scans after two to three treatment cycles, typically spanning six to nine weeks. Some patients notice symptom improvements like reduced pain or better appetite within several weeks as the chemotherapy shrinks tumours. Response timing varies significantly based on cancer type, disease stage, and whether Irinotecan is used alone or combined with other cancer medications. Blood tests monitoring tumour markers may show earlier indications of treatment effectiveness before physical changes are visible.

When and how should I take Irinotel 100mg/5ml?

Irinotel 100mg/5ml is administered exclusively as an intravenous infusion by trained healthcare professionals in clinical settings, never as a self-administered medication at home. Your oncologist will determine the precise dosing schedule, commonly given once weekly or once every two to three weeks depending on your treatment protocol. The chemotherapy infusion typically lasts thirty to ninety minutes. Timing between doses allows your body to recover from the medication's effects on both cancer cells and healthy rapidly-dividing cells. Your cancer specialist will adjust the schedule and dose based on blood counts, side effect severity, and treatment response throughout your therapy course.

Is Irinotel 100mg/5ml safe for long-term use?

Irinotel 100mg/5ml safety for extended treatment depends entirely on individual response, tolerability, and ongoing disease status. Oncologists carefully monitor patients receiving prolonged Irinotecan therapy through regular blood tests checking liver function, kidney function, and blood cell counts. Some patients continue this chemotherapy agent for many months when it effectively controls cancer growth with manageable adverse effects. Long-term use requires vigilant assessment of cumulative toxicity risks, particularly bone marrow suppression and gastrointestinal complications. Duration of therapy balances cancer control benefits against potential harm, with treatment continuing as long as the disease responds without unacceptable toxicity developing.

Can I take Irinotel 100mg/5ml with other medicines?

Irinotel 100mg/5ml frequently interacts with numerous medications, making comprehensive medication review essential before starting this chemotherapy treatment. Strong CYP3A4 enzyme inhibitors like ketoconazole or clarithromycin can dangerously increase Irinotecan levels, while enzyme inducers such as phenytoin or St. John's Wort may reduce effectiveness. Certain vaccines, particularly live vaccines, should be avoided during treatment with this immunosuppressive cancer medicine. Many patients receive Irinotel alongside other chemotherapy agents like fluorouracil or targeted cancer therapies as part of combination regimens specifically designed by oncologists. Always inform your cancer care team about all prescription medications, supplements, and herbal products you're taking.

How does Irinotel 100mg/5ml compare to similar medicines in its class?

Irinotel 100mg/5ml belongs to the topoisomerase inhibitor class alongside medications like topotecan, which treats different cancer types. Compared to topotecan, Irinotecan demonstrates superior effectiveness specifically for colorectal cancer treatment and offers more flexible dosing schedules. Within colorectal cancer therapy, this chemotherapy agent has largely replaced older treatments due to improved survival outcomes when combined with fluorouracil-based regimens. Liposomal formulations of Irinotecan exist offering different pharmacokinetic profiles and potentially reduced toxicity for pancreatic cancer patients. Each topoisomerase inhibitor has distinct approved indications, side effect profiles, and administration requirements, making them non-interchangeable despite sharing the same mechanism of action.

Is the generic Irinotecan as effective as branded versions?

Generic Irinotecan formulations deliver identical therapeutic effectiveness as branded versions like Irinotel 100mg/5ml because they contain the same active pharmaceutical ingredient at equivalent concentrations. Regulatory authorities in the USA, UK, Canada, and Australia require generic chemotherapy medications to demonstrate bioequivalence to brand-name products through rigorous testing before approval. Oncologists routinely prescribe generic Irinotecan with full confidence in its anti-cancer activity and safety profile. The primary differences lie in inactive ingredients, packaging, and cost rather than clinical outcomes. Choosing between generic and branded topoisomerase inhibitors often depends on availability, insurance coverage, and pharmacy sourcing rather than efficacy concerns.

Why do patients choose PremiumRxDrugs for Irinotel 100mg/5ml?

Patients select PremiumRxDrugs for Irinotel 100mg/5ml because, as a trusted pharmacy, we combine medication authenticity guarantees with practical benefits cancer patients need. Our competitive pricing on chemotherapy medications helps manage treatment costs without compromising quality. We source all cancer medicines directly from manufacturers, eliminating counterfeit risks that plague oncology drug markets. Discreet packaging protects patient privacy, while flexible shipping options including free delivery on qualifying orders serve international customers across multiple continents. Our streamlined reorder system and prescription management tools simplify ongoing treatment logistics. Having earned patients' trust over more than 10 years, PremiumRxDrugs provides reliable access to essential cancer medications and responsive customer support.

What are the common side effects of Irinotecan?

Irinotecan commonly causes diarrhea, which can be severe and potentially dangerous if not managed promptly with antidiarrheal medications and hydration. Nausea, vomiting, and appetite loss affect many patients receiving this chemotherapy agent. Bone marrow suppression leads to low white blood cell counts increasing infection risk, low platelet counts causing bleeding tendency, and anemia producing fatigue. Hair thinning or loss occurs frequently during treatment cycles. Acute cholinergic syndrome may develop during or shortly after infusion, causing sweating, abdominal cramping, and watery eyes. Fatigue and weakness are nearly universal experiences. Most adverse effects are temporary and resolve between treatment cycles, though severity varies considerably among individuals.

Who should avoid taking Irinotecan?

Irinotecan is contraindicated in patients with severe bone marrow dysfunction or significantly reduced blood cell counts before treatment initiation. Individuals with known hypersensitivity to this topoisomerase inhibitor or any formulation components should avoid this chemotherapy medication. Patients with severe liver impairment face increased toxicity risks and typically cannot safely receive standard Irinotecan dosing. Those with chronic inflammatory bowel disease may experience dangerously worsened diarrhea complications. Pregnancy and breastfeeding represent absolute contraindications due to serious fetal harm risks from this cancer treatment. Genetic variations affecting UGT1A1 enzyme activity increase severe toxicity likelihood, sometimes requiring dose adjustments or alternative therapies based on pharmacogenomic testing results.

Customer's Review
Copyright © 2026 PremiumRxDrugs. All rights reserved